Northern Trust Corp raised its position in Xometry, Inc. (NASDAQ:XMTR - Free Report) by 11.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 408,419 shares of the company's stock after purchasing an additional 40,889 shares during the quarter. Northern Trust Corp owned 0.82% of Xometry worth $17,423,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Summit Investment Advisors Inc. raised its position in Xometry by 8.1% in the 4th quarter. Summit Investment Advisors Inc. now owns 4,447 shares of the company's stock worth $190,000 after purchasing an additional 333 shares during the period. Global Retirement Partners LLC purchased a new stake in Xometry in the 4th quarter worth about $27,000. Arizona State Retirement System raised its position in Xometry by 7.9% in the 4th quarter. Arizona State Retirement System now owns 12,180 shares of the company's stock worth $520,000 after purchasing an additional 891 shares during the period. Canada Pension Plan Investment Board purchased a new stake in Xometry in the 4th quarter worth about $38,000. Finally, MetLife Investment Management LLC raised its position in Xometry by 5.0% in the 4th quarter. MetLife Investment Management LLC now owns 26,086 shares of the company's stock worth $1,113,000 after purchasing an additional 1,241 shares during the period. 97.31% of the stock is owned by hedge funds and other institutional investors.
Xometry Trading Up 3.6%
Shares of NASDAQ:XMTR traded up $1.18 during trading on Friday, reaching $34.29. 582,009 shares of the company were exchanged, compared to its average volume of 597,996. The firm has a market capitalization of $1.72 billion, a PE ratio of -32.66 and a beta of 0.71. The business's fifty day simple moving average is $25.43 and its 200-day simple moving average is $30.64. Xometry, Inc. has a 12-month low of $11.08 and a 12-month high of $45.33. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.59 and a quick ratio of 4.55.
Insider Activity
In other news, Director Emily Rollins sold 2,000 shares of the stock in a transaction that occurred on Monday, April 7th. The shares were sold at an average price of $20.66, for a total transaction of $41,320.00. Following the transaction, the director now directly owns 16,146 shares in the company, valued at approximately $333,576.36. This trade represents a 11.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Randolph Altschuler sold 27,566 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $26.60, for a total transaction of $733,255.60. Following the transaction, the chief executive officer now owns 256,570 shares in the company, valued at approximately $6,824,762. This represents a 9.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 85,297 shares of company stock worth $2,214,438. Corporate insiders own 9.66% of the company's stock.
Wall Street Analyst Weigh In
XMTR has been the topic of a number of recent analyst reports. Citigroup reduced their price objective on shares of Xometry from $46.00 to $39.00 and set a "buy" rating on the stock in a research report on Thursday, February 27th. JMP Securities reaffirmed a "market outperform" rating and set a $42.00 target price on shares of Xometry in a research report on Monday, February 10th. JPMorgan Chase & Co. reduced their target price on shares of Xometry from $45.00 to $30.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 22nd. The Goldman Sachs Group raised their target price on shares of Xometry from $30.00 to $33.00 and gave the stock a "buy" rating in a research report on Thursday, May 8th. Finally, Royal Bank of Canada raised their target price on shares of Xometry from $32.00 to $36.00 and gave the stock a "sector perform" rating in a research report on Wednesday, May 7th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $34.89.
Check Out Our Latest Stock Report on XMTR
Xometry Profile
(
Free Report)
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
See Also

Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.